Photo by Nwato
It is expected that the compound annual growth rate will reach 7.22% by 2028.
The global heparin market is expected to grow by $3.34b by 2028, driven by rising prevalence of coagulation disorders and rising R&D activities and new therapeutic applications.
A report by Technavio shows that the industry is expected to grow at a CAGR of 7.22% during the forecast period.
“Unfractionated heparin and plasma-derived therapies from animal sources such as cattle and pigs are both popular,” it said.
Furthermore, the market is driven by the development of heparin formulations, especially graded and low molecular weight variants for thrombus management.
Key patient groups include the elderly, accident victims and patients with chronic diseases. Increases in orthopedic disease and surgical procedures have also stimulated the use of heparin.
Join the Asian Healthcare Magazine Community
Now that you're here…
….There are many ways you can work with us to promote your company and connect with your customers. Our team can help you plan and create print and digital advertising campaigns on this website and in the print magazine.
We can also organize real-life or digital events for you and source thought-leader speakers as well as industry leaders (who could be your potential partners) to attend your events. We also run a number of awards programs that give you the opportunity to be recognized for your achievements during the year, and you can join as a participant or sponsor.
Let us help you drive business development through good partnerships!
